Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.

beta2-Glycoprotein I (beta2GPI), a plasma glycoprotein with phospholipid-binding property, is known to be the actual target antigen for autoimmune type anticardiolipin antibodies (aCLs). Certain groups of aCLs (anti-beta2GPI antibodies) exert lupus anticoagulant (LA) activity and perturb the functio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Takeya, H., Mori, T., Gabazza, E. C., Kuroda, K., Deguchi, H., Matsuura, E., Ichikawa, K., Koike, T., Suzuki, K.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 1997
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC508058/
https://ncbi.nlm.nih.gov/pubmed/9151800
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars